Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro.
Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro.
复制标题
生菜提取物中的 Luteolin-7-O-Glucoside 可在体外抑制人肝癌细胞产生乙型肝炎表面抗原和病毒复制。
DOI:
10.3389/fmicb.2017.02425
复制
发表时间:
2017
影响因子:
5.2
通讯作者:
Zhao C
中科院分区:
文献类型:
--
作者:
Cui XX;Yang X;Wang HJ;Rong XY;Jing S;Xie YH;Huang DF;Zhao C
Hepatitis B virus (HBV) infection is endemic in Asia and chronic hepatitis B (CHB) is a major public health issue worldwide. Current treatment strategies for CHB are not satisfactory as they induce a low rate of hepatitis B surface antigen (HBsAg) loss. Extracts were prepared from lettuce hydroponically cultivated in solutions containing glycine or nitrate as nitrogen sources. The lettuce extracts exerted potent anti-HBV effects in HepG2 cell lines in vitro, including significant HBsAg inhibition, HBV replication and transcription inhibition, without exerting cytotoxic effects. When used in combination interferon-alpha 2b (IFNα-2b) or lamivudine (3TC), the lettuce extracts synergistically inhibited HBsAg expression and HBV replication. By using differential metabolomics analysis, Luteolin-7-O-glucoside was identified and confirmed as a functional component of the lettuce extracts and exhibited similar anti-HBV activity as the lettuce extracts in vitro. The inhibition rate on HBsAg was up to 77.4%. Moreover, both the lettuce extracts and luteolin-7-O-glucoside functioned as organic antioxidants and, significantly attenuated HBV-induced intracellular reactive oxygen species (ROS) accumulation. Luteolin-7-O-glucoside also normalized ROS-induced mitochondrial membrane potential damage, which suggests luteolin-7-O-glucoside inhibits HBsAg and HBV replication via a mechanism involving the mitochondria. Our findings suggest luteolin-7-O-glucoside may have potential value for clinical application in CHB and may enhance HBsAg and HBV clearance when used as a combination therapy.
登录
查看更多内容
影响因子:
3.7
作者:
Lin J;Gu C;Shen Z;Liu Y;Wang W;Tao S;Cui X;Liu J;Xie Y
通讯作者:
Xie Y
影响因子:
4.9
作者:
Ladner, SK;Otto, MJ;King, RW
通讯作者:
King, RW
DOI:
10.1073/pnas.84.4.1005
发表时间:
1987-02-01
影响因子:
11.1
作者:
SELLS, MA;CHEN, ML;ACS, G
通讯作者:
ACS, G
影响因子:
25.7
作者:
Lucifora, Julie;Arzberger, Silke;Protzer, Ulrike
通讯作者:
Protzer, Ulrike
影响因子:
29.4
作者:
Phillips S;Chokshi S;Chatterji U;Riva A;Bobardt M;Williams R;Gallay P;Naoumov NV
通讯作者:
Naoumov NV